- Report
- October 2024
- 199 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 59 Pages
Asia Pacific
From €2524EUR$2,655USD£2,120GBP
€2804EUR$2,950USD£2,356GBP
- Report
- June 2024
- 67 Pages
Europe
From €2524EUR$2,655USD£2,120GBP
€2804EUR$2,950USD£2,356GBP
- Report
- January 2025
- 133 Pages
Europe
From €3803EUR$4,000USD£3,195GBP
- Report
- October 2024
- 195 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2024
- 137 Pages
Global
From €4235EUR$4,455USD£3,558GBP
€4706EUR$4,950USD£3,953GBP
- Report
- November 2023
- 170 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2023
- 178 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2023
- 220 Pages
Global
€4558EUR$4,795USD£3,829GBP

The Synthetic Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Synthetic Hormones are drugs that are designed to mimic the effects of naturally occurring hormones in the body. These drugs are used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and growth hormone deficiencies. Synthetic Hormones are also used to treat menopausal symptoms, such as hot flashes and night sweats.
Synthetic Hormones are typically administered orally, through injections, or through topical creams. The market for Synthetic Hormones is expected to grow in the coming years due to the increasing prevalence of endocrine and metabolic disorders, as well as the aging population.
Some companies in the Synthetic Hormone market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more